Advanced search
Publication Cover
Pathology Volume 39, 2007 - Issue 6
Submit an article Journal homepage
12
Views
4
CrossRef citations to date
0
Altmetric
HAEMATOLOGY

Occult bone marrow involvement in patients with diffuse large B‐cell lymphoma: results of a pilot study

Dipti Talaulikar Departments of; HaematologyCorrespondence[email protected]
,
Jane E. Dahlstrom Departments of; Anatomical Pathology
,
Bruce Shadbolt Departments of; Epidemiology
,
Michelle McNiven Departments of; Molecular Pathology, The Canberra Hospital, Australian Capital Territory, Australia
,
Amy Broomfield Departments of; Epidemiology
&
Michael Pidcock Departments of; Haematology
Pages 580-585 | Received 18 Sep 2006, Accepted 26 Mar 2007, Published online: 06 Jul 2009

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Ja Young Seo, Junshik Hong, Kayeong Chun, Jihoon Jeong, Hyeongrae Cho, Kyung Hee Kim, Jinny Park, Jeong Yeal Ahn, Pil-Whan Park & Jae Hoon Lee. (2017) Prognostic significance of PCR-based molecular staging in patients with diffuse large B-cell lymphoma treated with R-CHOP immunochemotherapy. Leukemia & Lymphoma 58:2, pages 357-365.
Read now
Neta Goldschmidt, Fares Darawshy, Geffen Kleinstern, Elena Slyusarevsky, Galina Pogrebijski, Svetlana Krichevsky, Dina Ben-Yehuda & Moshe E. Gatt. (2017) The prognostic value of bone marrow involvement at the molecular level in aggressive lymphoma. Leukemia & Lymphoma 58:1, pages 45-52.
Read now
Hiroshi Arima, Hayato Maruoka, Koji Nasu, Sumie Tabata, Masayuki Kurata, Akiko Matsushita, Yukihiro Imai, Takayuki Takahashi & Takayuki Ishikawa. (2013) Impact of occult bone marrow involvement on the outcome of rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone therapy for diffuse large B-cell lymphoma. Leukemia & Lymphoma 54:12, pages 2645-2653.
Read now
Dipti Talaulikar & Jane E. Dahlstrom. (2009) Staging bone marrow in diffuse large B-cell lymphoma: the role of ancillary investigations. Pathology 41:3, pages 214-222.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.